Extrait du Registre européen des brevets

EP Citations: EP3131572

Cité dansRecherche
Type:Littérature brevet
N° de publication:WO2008073603  [XD]
 (SCRIPPS RESEARCH INST et al.) [XD] 1-8 * paragraph [0023]; claim - *
Cité dansRecherche internationale
Type:Littérature brevet
N° de publication:US2013280234  [X]
 (JACKSON CHRISTOPHER JOHN et al.) [X] 1-8 * Abstract; [0002]; [0017]-[0026]; [0016]; [0030]; [0034]; [0036] *
Type:Littérature brevet
N° de publication:WO2014005183  [X]
 (UNIV SYDNEY et al.) [X] 1-8 * Abstract; page 5 lines 1-3; page 11 lines 1-9; page 15 lines 12-24; page 18 lines 1-9 *
Type:Littérature brevet
N° de publication:WO2005007820  [A]
 (SCRIPPS RESEARCH INST et al.) [A] 1-8 * Abstract; [0048]; [0042] *
Type:Littérature non-brevet
Information sur la publication:[X]   MC KELVEY K ET AL.: "Activated Protein C: A regulator of numan epidermal keratinocyte function", WORLD J BIOL CHEM, vol. 5, no. 2, 26 May 2014 (2014-05-26), pages 169 - 179, XP055233306 [X] 1-8 * . Abstract; page 175 column 1 pagaragraph 4; page 174 column 1 last paragraph-page 174 column 2 *
DOI: http://dx.doi.org/10.4331/wjbc.v5.i2.169
Type:Littérature non-brevet
Information sur la publication:[A]   WILLIAMS PD ET AL.: "Preclinical Safety and Pharmacokinetic Profile of 3K3-APC, a Novel, Modified Activated Protein C for Ischemic Stroke", CURR PHARM DES., vol. 18, no. 27, 2012, pages 4215 - 4222, XP055233307 [A] 1-8 * . Abstract; Introduction at paragraphs 5-6; Discussion; Conclusion *
Type:Littérature non-brevet
Information sur la publication:[A]   WALKER CT ET AL.: "Activated protein C with reduced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact", BRAIN RES, vol. 1347, 2010, pages 125 - 131, XP027164200, ISSN: 0006-8993 [A] 1-8 * . Abstract; Section 2.2-2.3 *